Increased ACSL4 expression and reduced GPX4 levels observed in our study confirm ferroptosis activation in DSS-treated mice, consistent with the findings of Xu et al. (2020), who demonstrated ferroptosis as a critical contributor to epithelial cell death in IBD [44,45]. Here, ACSL4 is linked to inflammatory bowel disease.